Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study offers insights into treatment of FIP
cat
FIP is usually found in young cats that are less than three years old.
Researchers successfully treat cats in late stage of the disease

US vets have successfully managed to treat laboratory cats suffering from the advanced stage of feline infectious peritonitis (FIP), a previously 100 per cent fatal disease.

In a study published in the journal PLOS Pathogens, researchers from Kansas State University describe their success with an antiviral treatment that stops the virus replicating.

When treatment was started at a late stage of disease, the researchers found that the cats returned to normal health within 20 days or less.

FIP is usually found in young cats that are less than three years old. Caused by coronavirus infection, most cats do not develop any symptoms at all. Yet, a small percentage of cats do go on to develop FIP.

FIP occurs in two forms: wet or dry. The wet form is more common and can be characterised by an accumulation of fluids in the abdominal area or chest cavity.

Symptoms may include fever, jaundice, and weight loss. Once set in it can progress rapidly, resulting in death or euthanasia.

Because of the rapid progression of the disease, it has not been known whether antiviral drug treatment can be effective at reversing disease progression in an infected cat.

"This is the first time we showed experimental evidence of successful treatment of laboratory cats at an advanced clinical stage of FIP," said Yunjeong Kim, an associate professor in the college’s diagnostic medicine pathobiology department.

"The knowledge gained from this study is a step forward to understanding the pathogenesis of FIP and other coronavirus infections important in humans and animals.”

Dr Kim says that the next step will be to find out how effective the antiviral treatment is for cats with naturally acquired FIP.

Become a member or log in to add this story to your CPD history

RUMA CA&E extends survey deadline

News Story 1
 RUMA CA&E has extended the deadline for its online survey into vaccine availability.

Vets, SQPs, retailers and wholesalers will now have until Friday, 26 September at 5pm to submit their response.

The survey aims to further understanding into the vaccine supply challenges faced by the sector. It will also consider the short and long term impacts of disruption issues.

Insights are anonymous, and will be shared with industry stakeholders and government bodies.

The survey can be accessed here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com